IBD Patient Launches iPhone Application to Help Doctors Treat Crohn's and Ulcerative Colitis
Developed by a Crohn's patient with help from GI specialists, GI Monitor, an iPhone App launched by WellApps, Inc., allows patients with (IBD) Crohn's and Ulcerative
Colitis to track their symptoms and deliver accurate data to their doctors.
UPPER SADDLE RIVER, N.J., May 19 /PRNewswire/ -- We...
For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission
Abbott/Eisai's Humira Will Earn Decision Resources' Clinical Gold Standard Status for Ulcerative
Colitis in 2012, According to a New Report from Decision Resources
WALTHAM, Mass., April 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceu...
Celebrating UC Success Contest Seeks to Educate and Inspire Ulcerative Colitis Patients Ulcerative
Colitis "Quick Tips" Contest Winners will be Awarded Travel to CCFA California Event
NEW YORK, March 11 /PRNewswire-FirstCall/ -- For ulcerative
colitis (UC) patients, managing their everyday life can be a challenge, but with perseverance and experience, many have found ways to hel...
Supplement of probiotics provides a new therapy for ulcerative colitis
The animal and clinical studies indicated that gastrointestinal bacteria play an important role in the development of UC, and the supplement of probiotics was beneficial for UC. While Because of the specific damage site of UC and the different colonization of each bacterium, it is suggested that d...
Identification of genetic markers for ulcerative colitis could lead to treatment
This release is available in French .
Montreal, January 8, 2009 An international consortium of researchers, including major contribution from a team led by Dr. John D. Rioux, a professor of medicine at the Universit de Montral and the Montreal Heart Institute, has identified genetic marke...
Companies Pay a High Price for Employees With Crohn's Disease and Ulcerative Colitis, According to Study From Thomson Reuters
ANN ARBOR, Mich., Nov. 10 /PRNewswire/ -- A study published today in
the Journal of Occupational and Environmental Medicine found that annual
medical expenditures for Crohn's disease patients are more than three times
higher than those for a matched comparison group of patients. Similar
Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis?
It is believed that the generation of an exaggerated intestinal immune response to otherwise innocuous stimuli along with generation of oxygen free radicals plays a key role in the pathophysiology of UC. However, no disease-specific treatment for UC has yet emerged. Vitamin E is a major lipophilic...
Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
BASINGSTOKE, UK and PHILADELPHIA, US June 17 /PRNewswire-FirstCall/ --
Shire Limited (LSE: SHP, Nasdaq: SHPGY), the global specialty
biopharmaceutical company, today announced the publication of data from a
randomized, long-term safety and tolerability study (study 303) of
ulcerative colitis (...
Study underway to find an alternative cure for Crohn's disease and ulcerative colitis
CHICAGO Two research studies evaluating dietary changes and complementary medicine for the treatment of inflammatory bowel diseases (IBD) have been launched at Rush University Medical Center. Funded by the National Institute of Health, one study will look at the impact of mind/body medicine on p...
Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
TORONTO, April 7 /PRNewswire/ - Medical Futures Inc. has licensed
MUTAFLOR(R) for the North American market. MUTAFLOR(R) is a drug used in
remission maintenance of Ulcerative
Colitis. Since its discovery in 1917,
MUTAFLOR(R) has been available in the German marketplace through a
subsidiary of ...
Ulcerative in Medical Technology
Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
CHICAGO, June 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, presented the results of a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence with 5-aminosalicylic Acid Therapy: Results from a Lar...
Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
-- Phase 1 RDEA119 data expected in second half of 2008 --
-- Presentation at the Seventh Annual JMP Securities Research Conference on
May 21st canceled; webcast of corporate update scheduled during Ardea's Annual Stockholder Meeting on May 22nd at 9:30 a.m. PT --
SAN DIEGO, May...
Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
4.8 g/day dose using investigational 800 mg tablet demonstrated efficacy and was well tolerated in ASCEND III study
SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today
at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego,
California, 70 percent ...
New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
A Separate Retrospective Analysis of US Employer Claims Suggests a Benefit
of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among Employees with Inflammatory Bowel Disease
SAN DIEGO, May 20 /PRNewswire/ -- Data from a new analysis of the
Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- A post hoc analysis showing
time to symptom resolution data from a study (study 302) of Shire plc's
(LSE: SHP, Nasdaq: SHPGY) ulcerative
colitis (UC) drug, LIALDA(TM), will be
presented today at Digestive Disease Week (DDW). Study 302 (further
Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Presentation of Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week 2008
PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) announced today that it has initiated the Phase 2 clinical
development program of MDX-1100, a fully h...
Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
Findings reinforce the benefits of Asacol for ulcerative
AVENTURA, Fla., Dec. 5 /PRNewswire/ -- Data from two Phase III clinical
trials support that Asacol, an oral, non-steroidal medication that belongs
to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an
New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
Symptom resolution results based on stringent endpoint of clinical remission is more clinically relevant, beneficial to patients
PHILADELPHIA, Oct. 15 /PRNewswire-FirstCall/ -- An analysis of data to
be presented tomorrow at the American College of Gastroenterology (ACG)
Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term
Safety Study of Lialda (mesalamine) Presented at DDW
Post-hoc analysis shows nearly nine out of ten patients taking
once-daily Lialda remained relapse free at the end of 12 months
WASHINGTON, D.C., May 22, 2007 /PRNewswire-FirstCall/ -- A
long-term phase III, open-label 12-14 month extension study (303)
presented at the British Society of Gastroente...
Long-Term Extension of Ulcerative Colitis Study Shows Remicade
Responders Maintained Improvement Through Two Years of Follow-Up
Separate Survey Underscores Impact of Disease on Work Status and
WASHINGTON, May 23, 2007 /PRNewswire-FirstCall/ -- Findings
presented today at Digestive Disease Week(R) 2007 (DDW), from
long-term extensions of the ACT trials (Active Ulcerative
& 2) show that subjects wi...
Ulcerative in Medical Products
Description:... Intended to replace total contact casting for the treatment of ulcerative
or preulcerative conditions of the plantar surface of the foot. Other indications may include moderate to severe plantar fasciitis or other foot condi...
Bledsoe Tenderfoot Boot
Description:...soe Tenderfoot™ Boot features a more open design of our Automold™ Dual Density technology used in our Conformer boots. It is used to treat ulcerative
or pre-ulcerative foot conditions in sensate patients, plantar fasciitis, bone bruises (stone bruises), severe blisters or callouses, or any other foo...
Company:Bledsoe Brace Systems
IgE (Total) EIA Test Kit
Description:...have also been demonstrated to cause high levels of IgE.
Decreased levels of IgE are found in cases of
hypogammaglobulinemia, autoimmune diseases, ulcerative
hepatitis,cancer, and malaria. Cord blood or serum IgE levels may
have prognostic value in assessing the risk of future allergic
Ulcerative in Medical Definition
...ctose malabsorption , Whipple's ) - Lymphoma
Diarrhea - Appendicitis - Diverticulitis - Diverticulosis - IBD ( Crohn's , ulcerative
colitis ) - IBS - Constipation - Colorectal cancer - Hirschsprung's - Pseudomembranous colitis
Inguinal - Femoral - Um...
Ulcerative in Medical Dictionary
colitis is a form of inflammatory bowel disease (IBD). ulcerative
colitis is a form of colitis , a disease of ...s of several drugs and ... is the treatment for ulcerative
colitis ? Is colon cancer a ... ...
... toxic megacolon n A serious complication of ulcerative
colitis that may result in perforation of the ...h as ... Toxic megacolon is mainly seen in ulcerative
colitis and pseudomembranous ... MedlinePlus Enc... megacolon . Crohn's disease - affected areas. ulcerative
colitis ... Toxic megacolon occurs as a comp...
...aily health, fitness, and lifestyle destination. Type... Information on ulcerative
colitis as a medical condition with ulcerative
colitis ... The goal is to induce remission initially with medications,...
...lled rectal cancer. Cancer ... rectum , cancer cells are often found in ... Online Medical Dictionary and glossary with medical definitions ... ulcerative
proctitis:Ulcerative colitis that is limited to the rectum . ... ... shows that 39% of colon and rectum cancer cases are diagnosed while ...
...ne proctitis is associated with diseases such as ulcerative
colitis or Crohn's disease. ... Idiopathic ... to be a ... Symptoms of Proctitis ... About ulcerative
Colitis & Proctitis . How IBD is Diagnosed. P...ssible Complications ... One common subcategory of ulcerative
...vily used addictive drugs in the United States. ... Original Article from The New England Journal of Medicine -- Transdermal Nicotine for Active ulcerative
Colitis ... and plasma nicotine and cotinine ... A man about to use a piece of nicotine gum. ... The nicotine is delivered to the bloodstr...
... , the main sugar in milk and milk products - which can cause cramps, diarrhea, and gas. Lactose intolerance is not limited to people with ulcerative
colitis. ... Some are born with lactose intolerance. ... incidence of lactose intolerance is ... Treatment consists primarily of avoiding l...
...s of keratitis may resemble other conditions or medical problems. ... ulcerative
keratitis (corneal ulceration) means that the corneal epithelium and .....ormation by Drugs.com, including Keratitis advice. ... Keratitis may be ulcerative
(open sores) or non-ulcerative (no sores), and is ... Children's Memori...
...The hallmark of colitis is the biopsy finding of cryptitis ... Crohn's colitis , acute infectious colitis , and ischemic colitis can mimic ulcerative
colitis . ... Ischemic colitis due to obstruction of mesenteric and splenic veins: A case report ... chronic venous insufficiency is rare...
...cy and safety of anti-TNF therapy in the management of Crohn's disease, and discusses ... terminal ileum was characterized ... Introduction to ulcerative
colitis as a medical condition including symptoms, ... affects the small intestine except for the lower section, called the ileum . ... Regis...
Ulcerative in Biological News
New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
PITTSBURGH, Jan. 4 An international team led by University of Pittsburgh School of Medicine researchers has identified genetic markers associated with risk for ulcerative
colitis. The findings, which appear today as an advance online publication of the journal Nature Genetics , bring researchers...
Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of colectomy surgeries for patients with moderately to severely active ulcerative
colitis (UC). Accordin...
NIH expands Human Microbiome Project; funds sequencing centers and disease projects
... B. Young, M.D., Ph.D., University of Michigan, Ann Arbor
Digestive tract: ulcerative
Some patients who suffer from ulcerative
colitis, a type of inflammatory bowel disease that causes inflammation and ...
Enzyme involved in inflammatory bowel disease discovered at Penn State College of Medicine
...s to help the half-a-million Americans affected by ulcerative
colitis and Crohn's disease, collectively referred...lammation associated with both Crohn's disease and ulcerative
colitis with low meprin levels.
"This discover...anding the genetic control of inflammation, and of ulcerative
colitis and Crohn's disease in particular," Bond s...
Stem cell focus for IBD wound healing
The study could eventually lead to the development of new drugs which use natural molecules to spark the recovery of patients suffering from ulcerative
colitis and Crohn's disease, reducing their risk of associated complications such as scarring, bowel obstructions and tumour growth.
Funded with a ...
Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
...oimmune diseases including rheumatoid arthritis, ankylosing spondylitis and ulcerative
colitis. The safety and efficacy of anti-TNF therapies has been well estab...d to TNF blockade in Crohn's disease, psoriasis, ankylosing spondylitis and ulcerative
colitis," said Feldmann. "Blocking other cytokines such as IL-6 has been ...
New genes found for inflammatory bowel disease in children
...ase, which can affect any part of the gastrointestinal tract, and half have ulcerative
colitis, which is limited to the large intestine.
IBD that begins in ch...mized to each patient."
The study team also found an association between ulcerative
colitis and genes on the major histocompatiblity complex (MHC) on chromosom...
Weill Cornell science briefs June/July 2008
...ortant because most IBD-sufferers are young teens or in their 20s, and are the most likely patient-group to miss a dose.
IBD includes two diseases: ulcerative
colitis and Crohn's disease. Both cause inflammation in the gastrointestinal (GI) tract, leading to bloody diarrhea, abdominal pain and weight loss. D...
Getting better with a little help from our 'micro' friends
...microbe causes a disease in the mice that is similar to Crohn's disease and ulcerative
colitis. However, when the animals were co-colonized with B. fragilis, they...tellation of illnesses that cause inflammation in the intestines, including ulcerative
colitis and Crohn's disease, is estimated to affect one million Americans. ...
Inflammation triggers cell fusions that could protect neurons, Stanford research shows
...ose animals with higher-than-expected numbers of fused cells also had an inflammatory skin condition common to aging laboratory mice called idiopathic ulcerative
dermatitis. This type of chronic inflammation affects the entire immune system of the animal and causes a systemwide immune response.
Ulcerative in Biological Technology
Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis
As Part of "In the Zone for UC" Campaign, Centocor Ortho Biotech Inc. Will Donate $5,000 to the Crohn's & Colitis Foundation of America for Each Point Pisani Scores During 2008-2009 Season
HORSHAM, Pa., March 2 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today a partnership wit...
Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
Forms One of the Largest Sales Teams Promoting a 5-ASA Medicine
BASINGSTOKE, England and PHILADELPHIA, March 26 /PRNewswire-FirstCall/
-- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today a co-promotion agreement with
TAP Pharmaceutical Pr...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
- MEZAVANT for the treatment of ulcerative
colitis; launches will
continue in certain E...e 30, 2009 (2008: 27.6%).
LIALDA/MEZAVANT - ulcerative
Product sales of LIALDA/MEZAVANT fo...g and reimbursement
PENTASA - ulcerative
Sales of PENTASA(R) for the three m...
Schering-Plough Reports Financial Results for 2009 Second Quarter
...d arthritis, early rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, pediatric Crohn's disease and ulcerative
Global sales of NASONEX, an inhaled nasal corticosteroid for allergies, increased 3 percent to $321 million in the 2009 second quar...
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
...drug development candidates include TRIOLEX(R) (HE3286), a next-generation compound currently in clinical trials for the treatment of type 2 diabetes, ulcerative
colitis and rheumatoid arthritis, and APOPTONE(R) (HE3235), a next-generation compound in a clinical trial for the treatment of late-stage prostate ca...
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
... many as half a million Americans. People with Crohn's can experience an ongoing cycle of flare-up and remission throughout their lives. Together with ulcerative
colitis, Crohn's disease is an inflammatory bowel disease (IBD).
About CIMZIA (R) (certolizumab pegol)
Cimzia(R) is the only PEGylated anti...
ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week
...estine causes persistent inflammation that may result in Crohn's disease or ulcerative
colitis - the two principal forms of IBD. In preclinical studies, the comp... both therapeutically and prophylactically in models of Crohn's disease and ulcerative
colitis. Traficet-EN may offer advantages over existing therapeutic approa...
The Crohn's & Colitis Foundation of America and Shire Launch Virtual 'IBD March on the Hill' to Increase Funding for Digestive Disease Research
... 646 943 7430
About Crohn's Disease & ulcerative
Crohn's disease and ulcerative
colitis are painful, medically incurable illnesses... attack anywhere from the mouth to the anus, while ulcerative
colitis inflames only the large intestine (colon)....
Shire begins the year with a strong performance
... - MEZAVANT(R) (mesalamine) for the treatment of ulcerative
certain EU countries during 2009;...h 31, 2009 (2008: 26.1%).
LIALDA/MEZAVANT - ulcerative
Product sales of LIALDA/MEZAVANT fo...g and reimbursement negotiations.
PENTASA - ulcerative
Sales of PENTASA for the three mont...
Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
...ry. The TARGIT system
offers the option of delivering high local concentrations of drug, which are
ideal for the topical treatment of diseases such as ulcerative
Crohn's disease, irritable bowel syndrome and bacterial infections. The
ability of TARGIT to reliably deliver drugs into the lower GIT has be...
Ulcerative in Biological Definition
Foot and mouth disease
...s have been recorded in countries of continental Europe , Africa, and South America. Symptoms of FMD in humans include malaise, fever, vomiting, red ulcerative
lesions (surface-eroding damaged spots) of the oral tissues, and sometimes vesicular lesions (small blisters) of the skin. There is another viral dis...